Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2022

Genmab — Oktober 2022

Planlagt Fastgjort Låst Flyttet Genmab
641 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #583

    Ja vi bliver klogere 9 Nov. og til den tid er der under 2 mdr tilbage af 2022 så de burde kunne reducere spændet med mingre der er en stor jocker som de stadig mener kan komme i hus inden udgang af 2022

    1 Reply Last reply
    0
    • H Offline
      H Offline
      henrik48
      wrote on sidst redigeret af
      #584

      Mon der bliver rødvin til,Pensionisten til aften 🙂

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #585

        Man kan jo sænke forventningerne til 2850 for at være på den sikre side

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #586

          congress.esgo
          1392
          Tisotumab Vedotin Combinations with Pembrolizumab or Carboplatin in Patients With Recurrent/Metastatic Cervical Cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205

          1. Cervical cancer Domenica Lorusso Italy Oral poster session 3 , 28 Oct 15:45-16:45
          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #587

            not sure if they will
            present anyting new

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #588

              there is also a poster - 1548
              Trial in Progress Update on ENGOT-cx8/GOG-3024/innovaTV 205:
              Addition of a New Cohort Using First-Line Tisotumab Vedotin +
              Pembrolizumab + Carboplatin ± Bevacizumab in

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #589

                EPCO....!

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #590

                  Tæller det som en god fredagsnyhed?

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #591

                    https://ir.genmab.com/news-releases/news-release-details/genmab-announces-submissions-regulatory-applications-epcoritamab Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) Forventet inden 31/12 🙂

                    1 Reply Last reply
                    0
                    • DarvinD Offline
                      DarvinD Offline
                      Darvin
                      wrote on sidst redigeret af
                      #592

                      Skal vi ikke bare sige ja - og glæde os til fyraften

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #593

                        En FDA ansøgning af Genmab mens EMA har accepteret Abbvie ansøgning

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          deleted-user
                          wrote on sidst redigeret af
                          #594

                          accepteret = "validated" - op til egen fortolkning

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #595

                            excellent! maybe AbbVie will confirm that accepted
                            in their Q3 call this afternoon

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #596

                              Kanon. Casen yderligere derisket

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bikube
                                wrote on sidst redigeret af
                                #597

                                Og så før lukketid - skønt.

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #598

                                  Så bliver der rødvin til Pensionisten

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #599

                                    som jeg lige husker har FDA 60 dage til at acceptere ansøgningen og det vil vel sige Genmab kan modtage deres milestone betaling senest 28 dec.

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #600

                                      så er spørgsmålet bare hvor stor betalingen bliver

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #601

                                        God fredagsnyhed 🙂

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #602

                                          Lækkert transatlantisk koncept til efterfølgelse.. de søger i hinandens forhaver.. og koordinerer GENs annoncering af sin indgivning af ansøgning til FDA - med AbbVies bekræftelse på at EMA har valideret deres ansøgning. Rigtig sjovt one-two punch.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper